26,377 HealthEquity, Inc. $HQY Shares Purchased by Moody Aldrich Partners LLC

Moody Aldrich Partners LLC grew its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 116.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 48,967 shares of the company’s stock after purchasing an additional 26,377 shares during the period. Moody Aldrich Partners LLC’s holdings in HealthEquity were worth $4,332,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in HQY. BlackRock Inc. acquired a new stake in shares of HealthEquity in the 2nd quarter valued at about $1,018,621,000. William Blair Investment Management LLC acquired a new position in HealthEquity during the 2nd quarter worth approximately $160,158,000. Bank of America Corp DE acquired a new position in HealthEquity during the 2nd quarter worth approximately $103,573,000. Atalan Capital Partners LP bought a new position in HealthEquity in the second quarter worth approximately $82,667,000. Finally, Jupiter Topco LLC bought a new position in HealthEquity in the second quarter worth approximately $78,847,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Up 0.5%

HealthEquity stock opened at $101.34 on Thursday. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $107.62. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.99 and a current ratio of 2.99. The firm’s 50-day simple moving average is $95.46 and its 200 day simple moving average is $88.91. The stock has a market cap of $8.38 billion, a PE ratio of 36.58, a price-to-earnings-growth ratio of 1.64 and a beta of 0.24.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Thursday, August 27th. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The firm had revenue of $350.73 million during the quarter, compared to analyst estimates of $349.22 million. The business’s revenue for the quarter was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Research analysts predict that HealthEquity, Inc. will post 3.93 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on HQY shares. Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, October 10th. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a research report on Friday, August 28th. BTIG Research reiterated a “buy” rating and issued a $115.00 target price on shares of HealthEquity in a report on Friday, August 28th. BMO Capital Markets lifted their price target on shares of HealthEquity from $105.00 to $125.00 and gave the company an “outperform” rating in a research report on Wednesday, October 21st. Finally, Barclays lifted their price target on shares of HealthEquity from $110.00 to $115.00 and gave the company an “overweight” rating in a research report on Friday, September 18th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $113.53.

Insider Activity

In other news, Director Adrian Dillon sold 7,632 shares of the company’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the completion of the transaction, the director directly owned 62,395 shares of the company’s stock, valued at $6,527,140.95. This represents a 10.90% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is currently owned by corporate insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company’s offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.